Patients with nonalcoholic fatty liver disease have higher risk of colorectal adenoma after negative baseline colonoscopy

Colorectal Disease

Volumn 15, Issue 7, 2013, Pages 830-835

  Huang, K W ^a,b   Leu, H B ^a,b   Wang, Y J ^a,b   Luo, J C ^a,b   Lin, H C ^a,b   Lee, F Y ^a,b   Chan, W L ^a,b   Lin, J K ^b   Chang, F Y ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Body mass index; Colorectal adenoma; Colorectal cancer; Metabolic syndrome; Nonalcoholic fatty liver disease

Indexed keywords

ADULT; ANTHROPOMETRY; ARTICLE; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL ADENOMA; COMPARATIVE STUDY; ECHOGRAPHY; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBIDITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING;

BODY MASS INDEX; COLORECTAL ADENOMA; COLORECTAL CANCER; METABOLIC SYNDROME; NONALCOHOLIC FATTY LIVER DISEASE;

ADENOMA; ADULT; AGE FACTORS; AGED; BODY MASS INDEX; COHORT STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; FATTY LIVER; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 84881007386     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12172     Document Type: Article

References (30)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Sung JJ, Lau JY, Young GP et al. Asia Pacific consensus recommendations for colorectal cancer screening. Gut 2008; 57: 1166-76.
3. Chu PC, Hwang JS, Wang JD, Chang YY. Estimation of the financial burden to the National Health Insurance for patients with major cancers in Taiwan. J Formos Med Assoc 2008; 107: 54-63.
4. Winawer SJ, Zauber AG, Ho MN et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993; 329: 1977-81.
5. Zauber AG, Winawer SJ, O'Brien MJ et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012; 366: 687-96.
6. Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 2007; 86: 556-65.
7. Yuhara H, Steinmaus C, Cohen SE, Corley DA, Tei Y, Buffler PA. Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol 2011;106:1911-21; quiz 1922.
8. Siddiqui AA. Metabolic syndrome and its association with colorectal cancer: a review. Am J Med Sci 2011; 341: 227-31.
9. Siddiqui A, Chang M, Mahgoub A, Sahdala HN. Increase in body size is associated with an increased incidence of advanced adenomatous colon polyps in male veteran patients. Digestion 2011; 83: 288-90.
10. Eddi R, Karki A, Shah A, Debari VA, Depasquale JR. Association of Type 2 diabetes and colon adenomas. J Gastrointest Cancer 2012; 43: 87-92.
11. Kim JH, Lim YJ, Kim YH et al. Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomarkers Prev 2007; 16: 1543-6.
12. Ortiz AP, Thompson CL, Chak A, Berger NA, Li L. Insulin resistance, central obesity, and risk of colorectal adenomas. Cancer 2012; 118: 1774-81.
13. Hwang ST, Cho YK, Park JH et al. Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps. J Gastroenterol Hepatol 2010; 25: 562-7.
14. Stadlmayr A, Aigner E, Steger B et al. Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia. J Intern Med 2011; 270: 41-9.
15. Wong VW, Wong GL, Tsang SW et al. High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. Gut 2011; 60: 829-36.
16. Touzin NT, Bush KN, Williams CD, Harrison SA. Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease. Therap Adv Gastroenterol 2011; 4: 169-76.
17. Han TS, van Leer EM, Seidell JC, Lean ME. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 1995; 311: 1401-5.
18. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004; 27: 1182-6.
19. Fan JG, Jia JD, Li YM et al. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166). J Dig Dis 2011; 12: 38-44.
20. Kim MC, Kim CS, Chung TH, Park HO, Yoo CI. Metabolic syndrome, lifestyle risk factors, and distal colon adenoma: a retrospective cohort study. World J Gastroenterol 2011; 17: 4031-7.
21. Morita T, Tabata S, Mineshita M, Mizoue T, Moore MA, Kono S. The metabolic syndrome is associated with increased risk of colorectal adenoma development: the Self-Defense Forces health study. Asian Pac J Cancer Prev 2005; 6: 485-9.
22. Tsilidis KK, Brancati FL, Pollak MN et al. Metabolic syndrome components and colorectal adenoma in the CLUE II cohort. Cancer Causes Control 2010; 21: 1-10.
23. Amarapurkar DN, Hashimoto E, Lesmana LA, Sollano JD, Chen PJ, Goh KL. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol 2007; 22: 788-93.
24. Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. QJM 2010; 103: 71-83.
25. Soardo G, Donnini D, Domenis L et al. Oxidative stress is activated by free fatty acids in cultured human hepatocytes. Metab Syndr Relat Disord 2011; 9: 397-401.
26. Feldstein AE, Werneburg NW, Canbay A et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 2004; 40: 185-94.
27. Wong VW, Hui AY, Tsang SW et al. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2006; 4: 1154-61.
28. Doyle SL, Donohoe CL, Lysaght J, Reynolds JV. Visceral obesity, metabolic syndrome, insulin resistance and cancer. Proc Nutr Soc 2012; 71: 181-9.
29. Levin B, Lieberman DA, McFarland B et al. American Cancer Society Colorectal Cancer Advisory Group, Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570-95.
30. U.S. Preventive Services Task Force, Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149:627-37.